OSR Health, Inc.: OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal
OSR Health, Inc. (NASDAQ:OSRH) received a Nasdaq staff delisting determination for failing to meet the minimum bid price requirement. The company plans to appeal, citing recent trading activity and business fundamentals. On August 17 and 18, 2026, OSRH traded 370 million and 145 million shares respectively, with a public float of 18.5 million shares.
How this was made
The 30-second read
Why it matters
The delisting determination puts the stock at risk of suspension, likely prompting a sell‑off.
Market read
Primary corporate action affecting OSRH; limited spillover to similar low‑price Nasdaq stocks.
What to watch
Potential for a reverse split or private placement to regain compliance.
Background
OSR Health is a healthcare holding company listed on Nasdaq under ticker OSRH.
Ticker impact
OSR Health received a Nasdaq Staff Delisting Determination for failing to meet the $1.00 minimum bid price requirement.
Expect downward pressure; consider exiting or hedging positions.
Delisting decisions are rare and typically trigger immediate sell‑offs, especially for micro‑caps with low float.
Market effects
Highlights compliance risk for other low‑price Nasdaq Capital Market stocks.
Limited to U.S. micro‑cap investors; no broader regional effect.
Minimal global impact; primarily a company‑specific event.
Counterpoint
If the company can quickly raise its price above $1, a rebound could occur post‑appeal.
Key entities
- CompanyOSR Health, Inc.
Subject of the delisting determination.
- RegulatorNasdaq Listing Qualifications Department
Issued the staff delisting determination.
